T-bet in disease (original) (raw)

• Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357 (1986).
  CAS PubMed Google Scholar
• Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).
  Article CAS PubMed Google Scholar
• Zheng, W. & Flavell, R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596 (1997).
  Article CAS PubMed Google Scholar
• Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Article CAS PubMed Google Scholar
• Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Hwang, E.S., Szabo, S.J., Schwartzberg, P.L. & Glimcher, L.H. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307, 430–433 (2005).
  CAS PubMed Google Scholar
• Lazarevic, V. et al. T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat. Immunol. 12, 96–104 (2011).
  CAS PubMed Google Scholar
• Villarino, A.V., Gallo, E. & Abbas, A.K. STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms. J. Immunol. 185, 6461–6471 (2010).
  CAS PubMed Google Scholar
• Esensten, J.H., Lee, M.R., Glimcher, L.H. & Bluestone, J.A. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J. Immunol. 183, 75–82 (2009).
  CAS PubMed Google Scholar
• Wang, J. et al. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J. Clin. Invest. 116, 414–421 (2006).
  CAS PubMed PubMed Central Google Scholar
• Sullivan, B.M., Juedes, A., Szabo, S.J., von Herrath, M. & Glimcher, L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100, 15818–15823 (2003).
  CAS PubMed PubMed Central Google Scholar
• Peng, S.L., Szabo, S.J. & Glimcher, L.H. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99, 5545–5550 (2002).
  CAS PubMed PubMed Central Google Scholar
• Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Va14i NKT cells. Immunity 20, 477–494 (2004).
  CAS PubMed Google Scholar
• Afkarian, M. et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549–557 (2002).
  CAS PubMed Google Scholar
• Lighvani, A.A. et al. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98, 15137–15142 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mullen, A.C. et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292, 1907–1910 (2001).
  Article CAS PubMed Google Scholar
• Schulz, E.G., Mariani, L., Radbruch, A. & Hofer, T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-γ and interleukin-12. Immunity 30, 673–683 (2009).
  CAS PubMed Google Scholar
• Hu, X. & Ivashkiv, L.B. Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases. Immunity 31, 539–550 (2009).
  CAS PubMed PubMed Central Google Scholar
• Jenner, R.G. et al. The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc. Natl. Acad. Sci. USA 106, 17876–17881 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lord, G.M. et al. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106, 3432–3439 (2005).
  CAS PubMed PubMed Central Google Scholar
• Sullivan, B.M. et al. Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-γ production. J. Immunol. 175, 4593–4602 (2005).
  CAS PubMed Google Scholar
• Szabo, S.J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338–342 (2002).
  CAS PubMed Google Scholar
• Hultgren, O.H., Verdrengh, M. & Tarkowski, A. T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect. 6, 529–535 (2004).
  CAS PubMed Google Scholar
• Ravindran, R., Foley, J., Stoklasek, T., Glimcher, L.H. & McSorley, S.J. Expression of T-bet by CD4 T cells is essential for resistance to Salmonella infection. J. Immunol. 175, 4603–4610 (2005).
  CAS PubMed Google Scholar
• Neurath, M.F. et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195, 1129–1143 (2002).
  CAS PubMed PubMed Central Google Scholar
• Bettelli, E. et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79–87 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lovett-Racke, A.E. et al. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21, 719–731 (2004).
  CAS PubMed Google Scholar
• Juedes, A.E., Rodrigo, E., Togher, L., Glimcher, L.H. & von Herrath, M.G. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 199, 1153–1162 (2004).
  CAS PubMed PubMed Central Google Scholar
• Flynn, J.L. et al. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249–2254 (1993).
  CAS PubMed Google Scholar
• Huang, S. et al. Immune response in mice that lack the interferon-γ receptor. Science 259, 1742–1745 (1993).
  CAS PubMed Google Scholar
• Harty, J.T. & Bevan, M.J. Specific immunity to Listeria monocytogenes in the absence of IFN γ. Immunity 3, 109–117 (1995).
  CAS PubMed Google Scholar
• Way, S.S. & Wilson, C.B. Cutting edge: immunity and IFN-γ production during Listeria monocytogenes infection in the absence of T-bet. J. Immunol. 173, 5918–5922 (2004).
  CAS PubMed Google Scholar
• Fuss, I.J. et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157, 1261–1270 (1996).
  CAS PubMed Google Scholar
• Plevy, S.E. et al. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159, 6276–6282 (1997).
  CAS PubMed Google Scholar
• Targan, S.R., Deem, R.L., Liu, M., Wang, S. & Nel, A. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J. Immunol. 154, 664–675 (1995).
  CAS PubMed Google Scholar
• Matsuoka, K. et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 53, 1303–1308 (2004).
  CAS PubMed PubMed Central Google Scholar
• Yang, Y., Xu, J., Niu, Y., Bromberg, J.S. & Ding, Y. T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J. Immunol. 181, 8700–8710 (2008).
  CAS PubMed Google Scholar
• Sasaki, Y. et al. Identification of a novel type 1 diabetes susceptibility gene, T-bet. Hum. Genet. 115, 177–184 (2004).
  CAS PubMed Google Scholar
• Hultgren, B., Huang, X., Dybdal, N. & Stewart, T.A. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45, 812–817 (1996).
  CAS PubMed Google Scholar
• Serreze, D.V. et al. Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 49, 2007–2011 (2000).
  CAS PubMed Google Scholar
• Kaplan, M.H., Schindler, U., Smiley, S.T. & Grusby, M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313–319 (1996).
  CAS PubMed Google Scholar
• Kurata, H., Lee, H.J., O'Garra, A. & Arai, N. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11, 677–688 (1999).
  CAS PubMed Google Scholar
• Zhu, J., Guo, L., Watson, C.J., Hu-Li, J. & Paul, W.E. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166, 7276–7281 (2001).
  CAS PubMed Google Scholar
• Djuretic, I.M. et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8, 145–153 (2007).
  CAS PubMed Google Scholar
• Avni, O. et al. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3, 643–651 (2002).
  CAS PubMed Google Scholar
• Finotto, S. et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295, 336–338 (2002).
  CAS PubMed Google Scholar
• Finotto, S. et al. Asthmatic changes in mice lacking T-bet are mediated by IL-13. Int. Immunol. 17, 993–1007 (2005).
  CAS PubMed Google Scholar
• Munthe-Kaas, M.C. et al. T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children. J. Allergy Clin. Immunol. 121, 51–56 (2008).
  CAS PubMed Google Scholar
• Raby, B.A. et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 173, 64–70 (2006).
  CAS PubMed Google Scholar
• Kiwamoto, T. et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am. J. Respir. Crit. Care Med. 174, 142–151 (2006).
  CAS PubMed Google Scholar
• Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
  CAS PubMed Google Scholar
• Ivanov, I.I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
  CAS PubMed Google Scholar
• Mangan, P.R. et al. Transforming growth factor-beta induces development of the TH17 lineage. Nature 441, 231–234 (2006).
  CAS PubMed Google Scholar
• Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).
  CAS PubMed Google Scholar
• Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484–487 (2007).
  CAS PubMed PubMed Central Google Scholar
• Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967–974 (2007).
  CAS PubMed Google Scholar
• Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480–483 (2007).
  CAS PubMed Google Scholar
• Brustle, A. et al. The development of inflammatory TH-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958–966 (2007).
  PubMed Google Scholar
• Schraml, B.U. et al. The AP-1 transcription factor Batf controls TH17 differentiation. Nature 460, 405–409 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zhang, F., Meng, G. & Strober, W. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297–1306 (2008).
  CAS PubMed PubMed Central Google Scholar
• Mukasa, R. et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616–627 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bending, D. et al. Epigenetic changes at il12rb2 and tbx21 in relation to plasticity behavior of th17 cells. J. Immunol. 186, 3373–3382 (2011).
  CAS PubMed Google Scholar
• Doodes, P.D. et al. IFN-γ regulates the requirement for IL-17 in proteoglycan-induced arthritis. J. Immunol. 184, 1552–1559 (2010).
  CAS PubMed Google Scholar
• Rutitzky, L.I., Smith, P.M. & Stadecker, M.J. T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation. Eur. J. Immunol. 39, 2470–2481 (2009).
  CAS PubMed PubMed Central Google Scholar
• Yuan, X. et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med. 205, 3133–3144 (2008).
  CAS PubMed PubMed Central Google Scholar
• Guo, S., Cobb, D. & Smeltz, R.B. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner. J. Immunol. 182, 6179–6186 (2009).
  CAS PubMed Google Scholar
• Durrant, D.M., Gaffen, S.L., Riesenfeld, E.P., Irvin, C.G. & Metzger, D.W. Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J. Immunol. 183, 5293–5300 (2009).
  CAS PubMed Google Scholar
• Furuta, S. et al. Overlapping and distinct roles of STAT4 and T-bet in the regulation of T cell differentiation and allergic airway inflammation. J. Immunol. 180, 6656–6662 (2008).
  CAS PubMed Google Scholar
• Manoury-Schwartz, B. et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol. 158, 5501–5506 (1997).
  CAS PubMed Google Scholar
• Vermeire, K. et al. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol. 158, 5507–5513 (1997).
  CAS PubMed Google Scholar
• Nistala, K. et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. USA 107, 14751–14756 (2010).
  CAS PubMed PubMed Central Google Scholar
• Cannon, G.W. et al. Double-blind trial of recombinant γ-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 32, 964–973 (1989).
  CAS PubMed Google Scholar
• Panitch, H.S., Hirsch, R.L., Schindler, J. & Johnson, K.P. Treatment of multiple sclerosis with γ interferon: exacerbations associated with activation of the immune system. Neurology 37, 1097–1102 (1987).
  CAS PubMed Google Scholar
• Skurkovich, S. et al. Randomized study of antibodies to IFN-γ and TNF-α in secondary progressive multiple sclerosis. Mult. Scler. 7, 277–284 (2001).
  CAS PubMed Google Scholar
• Ferber, I.A. et al. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5–7 (1996).
  CAS PubMed Google Scholar
• Willenborg, D.O., Fordham, S., Bernard, C.C., Cowden, W.B. & Ramshaw, I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223–3227 (1996).
  CAS PubMed Google Scholar
• Frisullo, G. et al. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84, 1027–1036 (2006).
  CAS PubMed Google Scholar
• Nos, C. et al. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis. Mult. Scler. 10, 413–416 (2004).
  CAS PubMed Google Scholar
• Liberman, A.C. et al. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21, 1177–1188 (2007).
  CAS PubMed Google Scholar
• Frisullo, G. et al. Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. Clin. Immunol. 124, 284–293 (2007).
  CAS PubMed Google Scholar
• Drulovic, J. et al. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment? J. Neuroimmunol. 215, 90–95 (2009).
  CAS PubMed Google Scholar
• Chen, Y. et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116, 1317–1326 (2006).
  CAS PubMed PubMed Central Google Scholar
• Yang, X.O. et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063–1075 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hu, Y. et al. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4307–4316 (2010).
  CAS PubMed Google Scholar
• Yang, Y. et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206, 1549–1564 (2009).
  CAS PubMed PubMed Central Google Scholar
• Reboldi, A. et al. C–C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514–523 (2009).
  CAS PubMed Google Scholar
• Kebir, H. et al. Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66, 390–402 (2009).
  CAS PubMed Google Scholar
• Abromson-Leeman, S., Bronson, R.T. & Dorf, M.E. Encephalitogenic T cells that stably express both T-bet and RORγt consistently produce IFNγ but have a spectrum of IL-17 profiles. J. Neuroimmunol. 215, 10–24 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ghoreschi, K. et al. Generation of pathogenic TH17 cells in the absence of TGF-β signalling. Nature 467, 967–971 (2010).
  CAS PubMed PubMed Central Google Scholar
• Chitnis, T. et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 108, 739–747 (2001).
  CAS PubMed PubMed Central Google Scholar
• Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).
  CAS PubMed Google Scholar
• Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011).
  CAS PubMed PubMed Central Google Scholar
• Koch, M.A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595–602 (2009).
  CAS PubMed PubMed Central Google Scholar
• Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).
  CAS PubMed Google Scholar
• Garrett, W.S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33–45 (2007).
  CAS PubMed PubMed Central Google Scholar
• Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+IL-10+Foxp3− effector T cells. Nat. Immunol. 9, 1347–1355 (2008).
  CAS PubMed PubMed Central Google Scholar
• Veldhoen, M. et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset. Nat. Immunol. 9, 1341–1346 (2008).
  CAS PubMed Google Scholar
• Jager, A., Dardalhon, V., Sobel, R.A., Bettelli, E. & Kuchroo, V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169–7177 (2009).
  PubMed Google Scholar
• Nurieva, R.I. et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138–149 (2008).
  CAS PubMed PubMed Central Google Scholar
• Nurieva, R.I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001–1005 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cruz-Guilloty, F. et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51–59 (2009).
  CAS PubMed PubMed Central Google Scholar
• Pearce, E.L. et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041–1043 (2003).
  CAS PubMed Google Scholar
• Intlekofer, A.M. et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6, 1236–1244 (2005).
  CAS PubMed Google Scholar
• Intlekofer, A.M. et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408–411 (2008).
  CAS PubMed PubMed Central Google Scholar
• Joshi, N.S. et al. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281–295 (2007).
  CAS PubMed PubMed Central Google Scholar
• Rao, R.R., Li, Q., Odunsi, K. & Shrikant, P.A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32, 67–78 (2010).
  PubMed PubMed Central Google Scholar
• Oldstone, M.B., Nerenberg, M., Southern, P., Price, J. & Lewicki, H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65, 319–331 (1991).
  CAS PubMed Google Scholar
• Ohashi, P.S. et al. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305–317 (1991).
  CAS PubMed Google Scholar
• Burrell, B.E., Csencsits, K., Lu, G., Grabauskiene, S. & Bishop, D.K. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J. Immunol. 181, 3906–3914 (2008).
  CAS PubMed Google Scholar
• Rangachari, M. et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 203, 2009–2019 (2006).
  CAS PubMed PubMed Central Google Scholar
• Gerth, A.J., Lin, L. & Peng, S.L. T-bet regulates T-independent IgG2a class switching. Int. Immunol. 15, 937–944 (2003).
  CAS PubMed Google Scholar
• Liu, N., Ohnishi, N., Ni, L., Akira, S. & Bacon, K.B. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4, 687–693 (2003).
  CAS PubMed Google Scholar
• Werneck, M.B., Lugo-Villarino, G., Hwang, E.S., Cantor, H. & Glimcher, L.H. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J. Immunol. 180, 8004–8010 (2008).
  CAS PubMed Google Scholar
• Lugo-Villarino, G., Ito, S., Klinman, D.M. & Glimcher, L.H. The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proc. Natl. Acad. Sci. USA 102, 13248–13253 (2005).
  CAS PubMed PubMed Central Google Scholar
• Lugo-Villarino, G., Maldonado-Lopez, R., Possemato, R., Penaranda, C. & Glimcher, L.H. T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 100, 7749–7754 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lipscomb, M.W. et al. Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro. J. Immunol. 183, 7250–7258 (2009).
  CAS PubMed Google Scholar
• Veiga, P. et al. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. USA 107, 18132–18137 (2010).
  CAS PubMed PubMed Central Google Scholar
• Garrett, W.S. et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16, 208–219 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hegazy, A.N. et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3+T-bet+ cell subset with combined Th2 and Th1 cell functions. Immunity 32, 116–128 (2010).
  CAS PubMed Google Scholar
• Lee, Y.K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92–107 (2009).
  CAS PubMed PubMed Central Google Scholar